Ovarian cancer vaccine shows promising results in human study

Immunotherapy has gained ground against a stubborn opponent: ovarian cancer. A personalized cancer vaccine is safe an...

Posted: Apr 12, 2018 6:38 AM
Updated: Apr 12, 2018 6:38 AM

Immunotherapy has gained ground against a stubborn opponent: ovarian cancer. A personalized cancer vaccine is safe and may lengthen the lives of ovarian cancer patients, a small clinical trial found.

The research, published Wednesday in the journal Science Translational Medicine, showed "significantly higher" overall survival at two years among patients who received the vaccine, compared with patients who did not.

85% of ovarian cancer patients relapse after treatment

"Personalized vaccines" inspire immune systems to fight cancer, a trial found

Ovarian cancer is a "silent killer" because often it goes unnoticed until it is diagnosed at a late stage. Treated with surgery followed by chemotherapy, most patients -- 85% -- relapse and ultimately develop resistance to the chemo. At this point, they run out of treatment options.

Still, scientists are hopeful based on the fact that a subset of patients shows an immune response to their cancer. Generally, these patients have better survival rates than those whose immune systems don't react in the same way.

A vaccine, then, might be able to trigger and boost the immune system and increase the survival rates of patients, said Dr. Lana Kandalaft, senior author of the new study and an adjunct assistant professor at the University of Pennsylvania Perelman School of Medicine.

Personalized medicine

Testing this hypothesis, Kandalaft and her colleagues created "personalized" vaccines for 25 patients diagnosed with advanced recurrent ovarian cancer. The women had recurrent advanced epithelial ovarian cancer, which has an average five-year survival rate of 17%, according to the American Cancer Society.

The scientists made each unique vaccine using a patient's tumor (stored and preserved before surgery) and dendritic cells from her blood.

Within the immune system, dendritic cells act as clever spies. Their mission is to identify foreign invaders lurking in the shadowy interfaces between our bodies and the environment: the lining of our airways, for example, and the surface of our intestines. Once they discover a virus or a dangerous toxin, dendritic cells will capture and display fragments of the invader on their surfaces and then travel deep into the lymph nodes, where the immune system's killer T cells reside.

Here, a simple introduction -- a knowing glance among friends -- takes place. The newly accessorized dendritic cells trigger the T cells to launch an attack in an attempt to destroy the invaders.

For the study, some patients received the personalized vaccine alone, and others received it in combination with either one or two chemo drugs (bevacizumab and cyclophosphamide).

"The patients who received the vaccine mounted an immune response against their own tumors," Kandalaft said in a statement. She described the immune response as "an increased number of T cells which were specific to the tumor and were able to kill tumors."

'Promising'

Each of the 25 patients received, on average, 16 vaccine shots over the course of the study and none experienced severe side effects from the vaccine.

Overall two-year survival was highest among responsive study patients who received the vaccine and two chemo drugs: Seventy-eight percent of vaccinated patients who also received the chemo drugs survived two years, compared with just 44% of patients who received the drugs but no vaccine.

Still, one vaccine-only patient remained in remission for five years after the study; prior to the study, her cancer had recurred twice after chemotherapy.

Dr. Otis Brawley, chief medical officer of the American Cancer Society, said the new study amounts to "good science" that "clearly justifies a larger clinical trial."

However, Brawley, who was not involved in the research, remains cautious of this "designer vaccine."

"Survival analysis is prone to some biases, which can mislead even the most experienced of clinical trialists," he said. The public "often wants to pass up better-proven conventional therapy for an unknown in immunotherapy."

Overall, Brawley is hopeful for immunotherapy as a treatment for ovarian cancer. "This methodology has been looked at in prostate cancer and may be useful in other diseases."

Going forward, Kandalaft and her colleagues will be pursuing larger studies of these vaccines. The results of the current study, designed to address safety and funded by National Institutes of Health, were "promising, albeit preliminary," she said.

West Lafayette
Scattered Clouds
31° wxIcon
Hi: 59° Lo: 42°
Feels Like: 31°
Kokomo
Clear
29° wxIcon
Hi: 55° Lo: 41°
Feels Like: 29°
Rensselaer
Clear
27° wxIcon
Hi: 57° Lo: 35°
Feels Like: 27°
Fowler
Clear
27° wxIcon
Hi: 57° Lo: 38°
Feels Like: 27°
Williamsport
Clear
31° wxIcon
Hi: 58° Lo: 41°
Feels Like: 31°
Crawfordsville
Clear
29° wxIcon
Hi: 58° Lo: 43°
Feels Like: 29°
Frankfort
Clear
31° wxIcon
Hi: 57° Lo: 41°
Feels Like: 31°
Delphi
Clear
29° wxIcon
Hi: 58° Lo: 41°
Feels Like: 29°
Monticello
Clear
29° wxIcon
Hi: 57° Lo: 40°
Feels Like: 29°
Logansport
Clear
30° wxIcon
Hi: 57° Lo: 39°
Feels Like: 30°
Dry Weekend with Coldest Weather of the Fall So Far on Sunday Night
WLFI Radar
WLFI Temps
WLFI Planner

Indiana Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 172730

Reported Deaths: 4260
CountyConfirmedDeaths
Marion26807796
Lake15074371
St. Joseph10092174
Elkhart9783146
Allen9123235
Hamilton6697120
Vanderburgh640572
Tippecanoe424616
Porter372351
Hendricks3532139
Monroe345038
Johnson3438132
Delaware326378
Clark318865
Vigo293042
Madison270398
LaPorte248867
Cass234426
Kosciusko219529
Warrick212166
Floyd193369
Howard176267
Wayne156933
Dubois155727
Marshall154930
Bartholomew153259
Grant141240
Henry140530
Boone134850
Hancock130244
Noble129335
Jackson125420
Dearborn109728
Lawrence104238
Morgan103040
Gibson98212
Clinton97816
Daviess96036
Shelby95737
Knox89210
LaGrange85115
Fayette84922
Harrison83524
DeKalb82413
Posey8058
Putnam80017
Jasper7395
Miami7205
Steuben7059
Montgomery66622
White65816
Adams6337
Greene60838
Scott57916
Decatur56239
Whitley5216
Ripley5178
Wabash5079
Wells50412
Huntington4985
Clay4927
Starke4929
Sullivan48114
Spencer4436
Randolph43911
Orange43625
Perry42114
Jefferson4165
Fulton4159
Washington4143
Jennings40213
Franklin39625
Jay3816
Pike37018
Carroll36413
Fountain3643
Tipton29423
Vermillion2911
Rush2734
Parke2724
Blackford2555
Newton24411
Owen2251
Martin2070
Pulaski1874
Crawford1691
Brown1523
Ohio1457
Union1280
Benton1160
Switzerland1070
Warren1021
Unassigned0236

COVID-19 Important links and resources

As the spread of COVID-19, or as it's more commonly known as the coronavirus continues, this page will serve as your one-stop for the resources you need to stay informed and to keep you and your family safe. CLICK HERE

Closings related to the prevention of the COVID-19 can be found on our Closings page.

Community Events